These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8779043)

  • 21. [Accidental transfusion with ABO-incompatible blood: process for analysis of the contributing causes].
    Indrikovs AJ
    Sangre (Barc); 1997 Jun; 42(3):205-13. PubMed ID: 9381263
    [No Abstract]   [Full Text] [Related]  

  • 22. Immune hemolysis following ABO-mismatched stem cell or solid organ transplantation.
    Yazer MH; Triulzi DJ
    Curr Opin Hematol; 2007 Nov; 14(6):664-70. PubMed ID: 17898572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Severe haemolysis due to passenger lymphocyte syndrome after an ABO mismatched bowel transplant--a case report.
    Davis SL; Vaidya A; Timbs A; Schuh A; Staves J; Murphy MF
    Transfus Med; 2011 Feb; 21(1):65-9. PubMed ID: 21062381
    [No Abstract]   [Full Text] [Related]  

  • 24. Alternative strategy for overcoming ABO incompatibility.
    Kobayashi T; Liu D; Ogawa H; Miwa Y; Nagasaka T; Maruyama S; Li YT; Onishi A; Kuzuya T; Kadomatsu K; Uchida K; Nakao A
    Transplantation; 2007 May; 83(9):1284-6. PubMed ID: 17496551
    [No Abstract]   [Full Text] [Related]  

  • 25. The role of isoagglutinins in intravenous immunoglobulin-related hemolysis.
    Bellac CL; Hottiger T; Jutzi MP; Bögli-Stuber K; Sänger M; Hanschmann KM; Keller-Stanislawski B; Funk MB
    Transfusion; 2015 Jul; 55 Suppl 2():S13-22. PubMed ID: 26174892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABO-incompatible kidney transplantation with anti-CD20 monoclonal antibodies, intravenous immunoglobulin and plasmapheresis without splenectomy: a case report.
    Imamura R; Ishiguro S; Shi Y; Namba Y; Ichimaru N; Isaka Y; Takahara S; Okuyama A
    Xenotransplantation; 2006 Mar; 13(2):133-5. PubMed ID: 16623807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Successful adult ABO-incompatible liver transplantation: therapeutic strategy for thrombotic microangiopathy is the key to success.
    Sekido H; Matsuo K; Takeda K; Morioka D; Kubota T; Tanaka K; Endo I; Togo S; Tanaka K; Shimada H
    Transplantation; 2003 May; 75(9):1605-7. PubMed ID: 12792527
    [No Abstract]   [Full Text] [Related]  

  • 28. Nonmyeloablative peripheral blood stem cell transplant for T-cell prolymphocytic leukaemia complicated by fulminant haemolysis and acute renal failure at engraftment secondary to minor ABO incompatibility.
    Curtin NJ; Schwarer AP
    Clin Lab Haematol; 2005 Jun; 27(3):206-8. PubMed ID: 15938729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safeguarding immune globulin recipients against hemolysis: what do we know and where do we go?
    Scott DE; Epstein JS
    Transfusion; 2015 Jul; 55 Suppl 2():S122-6. PubMed ID: 26174890
    [No Abstract]   [Full Text] [Related]  

  • 30. Apheresis platelet transfusions: does ABO matter?
    Herman JH; King KE
    Transfusion; 2004 Jun; 44(6):802-4. PubMed ID: 15157242
    [No Abstract]   [Full Text] [Related]  

  • 31. Consequences of ABO incompatibility in allogeneic hematopoietic stem cell transplantation.
    Stussi G; Muntwyler J; Passweg JR; Seebach L; Schanz U; Gmür J; Gratwohl A; Seebach JD
    Bone Marrow Transplant; 2002 Jul; 30(2):87-93. PubMed ID: 12132047
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a simple method for determination of IgG titre anti-A or-B in cases of possible ABO blood group incompatibility.
    Reesink HW; van der Hart M; van Loghem JJ
    Vox Sang; 1972; 22(5):397-407. PubMed ID: 5032414
    [No Abstract]   [Full Text] [Related]  

  • 33. Transfusion-related problems following major ABO-incompatible bone marrow transplantation.
    Tasaki T; Satoh S; Gotoh K; Fujii K; Sasaki S; Takadate J; Tachibana M; Ono Y; Ishida Y
    Transfus Apher Sci; 2003 Apr; 28(2):155-61. PubMed ID: 12679120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. First two ABO-incompatible living renal transplantations using splenectomy, rituximab, plasmapheresis and IVIG as a preconditioning regimen: a single center experience in the Balkans.
    Ivanovski N; Popov Z; Masin-Spasovska J; Dimcevska AH; Kolevski P
    Xenotransplantation; 2006 Mar; 13(2):123-5. PubMed ID: 16623805
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Significant numbers of apheresis-derived group O platelet units have "high-titer" anti-A/A,B: implications for transfusion policy.
    Josephson CD; Mullis NC; Van Demark C; Hillyer CD
    Transfusion; 2004 Jun; 44(6):805-8. PubMed ID: 15157243
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Potential approaches to prevent uncommon hemolytic side effects of AB0 antibodies in plasma derivatives.
    Buchta C; Macher M; Höcker P
    Biologicals; 2005 Mar; 33(1):41-8. PubMed ID: 15713555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Case of post-transfusion shock due to anti-Lewis antibodies].
    Kuśnierz G
    Pol Tyg Lek; 1971 May; 26(18):682-4. PubMed ID: 5090442
    [No Abstract]   [Full Text] [Related]  

  • 38. ABO-histo blood group incompatibility in hematopoietic stem cell and solid organ transplantation.
    Stussi G; Halter J; Schanz U; Seebach JD
    Transfus Apher Sci; 2006 Aug; 35(1):59-69. PubMed ID: 16935028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of hemolysis with high dose intravenous immunoglobulin therapy in pediatric patients: An open-label prospective trial.
    Akman AO; Kara FK; Koksal T; Cakir BC; Karagol C; Sayli T
    Transfus Apher Sci; 2017 Aug; 56(4):531-534. PubMed ID: 28818402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of inflammation in intravenous immune globulin-mediated hemolysis.
    Pendergrast J; Willie-Ramharack K; Sampson L; Laroche V; Branch DR
    Transfusion; 2015 Jul; 55 Suppl 2():S65-73. PubMed ID: 26174900
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.